← Leaderboards
Grant Nash Colfax
University Of California San Francisco
$39,745,322
Attributed
$43,307,004
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.1M · FY2005–11$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
CDC$32,398,185 · 7
NIH$10,908,819 · 7
By mechanism
U62$28,436,255 · 2
RC2$7,123,365 · 1
R01$2,629,477 · 3
U65$1,562,362 · 2
UR6$1,462,929 · 1
K23$845,782 · 1
Top collaborators
- Lisa R Metsch1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Reese T. Jones$7,250,168
- Tooru Nemoto$7,267,731
- Neal L Benowitz$31,329,042
- Kyung-Hee Choi$7,687,980
- Stephen L Eyre$4,734,865
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsInterviewClinical ResearchMethamphetamineHuman SubjectAlcohol Or Other Drugs UseBaseEnrollmentRisk ReductionRisk BehaviorsMen Who Have Sex With MenDesignSexually Transmitted DiseasesUnsafe SexPharmaceutical PreparationsCounselingRandomizedParticipantEpidemicHealth Care Service UtilizationBehaviorEventDependenceElectronics
Grant awards (37)
PS10-1001, HIV PREVENTION PROJECTS$9,143,991
U62 · FY2011 · PS · contact PI
The STOP Study$443,333
U01 · FY2011 · PS · contact PI
PS10-1001, HIV PREVENTION PROJECTS$9,268,980
U62 · FY2010 · PS · contact PI
IMPLEMENTING NEW DIRECTIONS IN HIV PREVENTION IN SAN FRANCISCO: A COMPREHENSIVE$887,968
U65 · FY2010 · PS · contact PI
PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS$877,273
U62 · FY2010 · PS · contact PI
Reducing HIV risk among episodic substance-using MSM$392,983
UR6 · FY2010 · PS · contact PI
Addressing Syndemics through Program Collaboration and Service Integration$326,640
U38 · FY2010 · PS · contact PI
The STOP Study$166,666
U01 · FY2010 · PS · contact PI
PS04-012, HIV PREVENTION PROJECTS$9,146,011
U62 · FY2009 · PS · contact PI
HIV Testing and Counseling in STD Clinics: an Adaptation of CTN 0032$7,123,365
RC2 · FY2009 · DA
Reducing HIV risk among episodic substance-using MSM$410,800
UR6 · FY2009 · PS · contact PI
Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviors$385,398
R01 · FY2009 · DA · contact PI
Reducing HIV risk among episodic substance-using MSM$379,933
UR6 · FY2008 · PS · contact PI
Mirtazapine to Reduce Methamphetamine Use Among MSM with High-Risk HIV Behaviors$355,912
R01 · FY2008 · DA · contact PI
Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM$273,804
R01 · FY2008 · DA · contact PI
Mirtazapine to Reduce Methamphetamine Use Among MSM with High-Risk HIV Behaviors$359,832
R01 · FY2007 · DA · contact PI
Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviors$339,450
R01 · FY2007 · DA · contact PI
Reducing HIV risk among episodic substance-using MSM$279,213
UR6 · FY2007 · PS · contact PI
Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM$276,531
R01 · FY2007 · DA · contact PI
Club-Drugs and HIV Risk Behavior in High-Risk Men$151,521
K23 · FY2007 · DA · contact PI
Reducing sexual risk fir HIV transmissoion in substance using msm$674,394
U65 · FY2006 · PS · contact PI
Mirtazapine to Reduce Methamphetamine Use Among MSM with High-Risk HIV Behaviors$353,988
R01 · FY2006 · DA · contact PI
Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk MSM$284,562
R01 · FY2006 · DA · contact PI
Club-Drugs and HIV Risk Behavior in High-Risk Men$168,386
K23 · FY2006 · DA · contact PI
Acceptability of pharmacologic treatment for methamphetamine dependence among MSM$82,108
R21 · FY2006 · DA · contact PI
Acceptability of pharmacologic treatment for methamphetamine dependence among MSM$228,087
R21 · FY2005 · DA
Club-Drugs and HIV Risk Behavior in High-Risk Men$164,362
K23 · FY2005 · DA
Reducing sexual risk fir HIV transmissoion in substance using msm$0
U65 · FY2005 · PS
Club-Drugs and HIV Risk Behavior in High-Risk Men$164,529
K23 · FY2004 · DA
Club-Drugs and HIV Risk Behavior in High-Risk Men$159,973
K23 · FY2003 · DA
Club-Drugs and HIV Risk Behavior in High-Risk Men$37,011
K23 · FY2003 · DA
HIV INFECTED EMERGENCY ROOM PATIENTS$0
M01 · FY2002 · RR
HIV INFECTED EMERGENCY ROOM PATIENTS$0
M01 · FY2002 · RR
HIV INFECTED EMERGENCY ROOM PATIENTS$0
M01 · FY2001 · RR
HIV INFECTED EMERGENCY ROOM PATIENTS$0
M01 · FY2000 · RR
HIV INFECTED EMERGENCY ROOM PATIENTS$0
M01 · FY2000 · RR
HIV INFECTED EMERGENCY ROOM PATIENTS$0
M01 · FY2000 · RR